| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 12/19/2007 | CN101088515A Chinese medicine for treating numbness and bradykunesia |
| 12/19/2007 | CN101088513A 生命技术及其应用 Life Technologies and Applications |
| 12/19/2007 | CN101088402A Health food for nursing face, protecting skin and blackening hair and its production process |
| 12/19/2007 | CN100355756C Therapeutic agent for schizophrenia |
| 12/19/2007 | CN100355753C Tropan derivatives useful in therapy, method for obtaining thereof and intermediate compounds |
| 12/19/2007 | CN100355751C 2-substd. 4-heteroaryl-pyrimidines and their use in treatment of proliferative disorders |
| 12/19/2007 | CN100355748C Aromatic hydrazide kind compound and its use in preparation of immune inhibitor |
| 12/19/2007 | CN100355731C Pyridinum derivatives for management of aging-related and diabetic vascular complications, process for their prepn. and therepeutic uses thereof |
| 12/19/2007 | CN100355728C Inhibitors of dipeptidyl peptidase IV |
| 12/19/2007 | CN100355714C Arylpiperazines having 5-hydroxyl-typtamine activity |
| 12/19/2007 | CN100355452C Carbonyl stress-ameliorating agents |
| 12/19/2007 | CN100355423C Combination comprising a vasculostatic compound and an alkylating agent for the treatmemt of a tumor |
| 12/19/2007 | CN100355419C Therapeutic agent for overactive bladder |
| 12/19/2007 | CN100355368C Health-care products with improving immunity and preventing radiative harm and production thereof |
| 12/18/2007 | US7310552 Apparatus for indirectly stimulating the vagus nerve with an electrical field |
| 12/18/2007 | US7309788 a selective N-alkylation reaction by adding a base; hydrolysing and amidating; useful for treating cardiovascular diseases caused by binding angiotensin II to its receptors, through antagonistic activity against angiotensin II receptors |
| 12/18/2007 | US7309721 Aminoalkylphosphonates and related compounds as Edg receptor agonists |
| 12/18/2007 | US7309718 Leukotriene D4 and E4 antagonists; antiasthmatic, antiallergic and antiinflammatory agents; oral absorbability, sustained action; such as [3-[(E)-2-(6,7-difluoroquinolin-2-yl)ethenyl]-5H-dibenzo[a,d]cyclohepten-5-yl]oxyacetic acid |
| 12/18/2007 | US7309710 Crystals |
| 12/18/2007 | US7309703 Substituted pyrazoles useful for treating autoimmune diseases mediated by cathepsin S |
| 12/18/2007 | US7309702 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; Alzheimer's disease |
| 12/18/2007 | US7309691 Combined pharmaceutical preparation containing LHRH-analogous substances and anti estrogens for treating gynaecological disorders |
| 12/18/2007 | US7309504 Therapeutic agent or preventor of hepatitis, TNF- alpha inhibitor, health supplementary food |
| 12/18/2007 | US7309502 Pharmaceutical compositions for treating and saving and the method for the preparation thereof |
| 12/18/2007 | CA2489763C Pharmaceutical salts of reboxetine |
| 12/18/2007 | CA2462459C Copolymers for suppression of autoimmune diseases, and methods of use |
| 12/18/2007 | CA2436799C Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders |
| 12/18/2007 | CA2299471C Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer |
| 12/18/2007 | CA2235400C Cartilage/bone inducing materials for reparation |
| 12/18/2007 | CA2229960C Steroid compounds having contraceptive and anti-osteoporosis activity |
| 12/18/2007 | CA2219070C Methods of preventing breast cancer |
| 12/13/2007 | WO2007143631A2 Nutraceutical treatments for diabetic and non-diabetic wound healing |
| 12/13/2007 | WO2007143317A2 Compounds and methods for modulating expression of crp |
| 12/13/2007 | WO2007143316A2 Compounds and methods for modulating expression of sglt2 |
| 12/13/2007 | WO2007143315A2 Compounds and methods for modulating expression of pcsk9 |
| 12/13/2007 | WO2007142369A1 Method for screening of anti-obesity agent |
| 12/13/2007 | WO2007142336A1 Gene involved in immortalization of human cancer cell and use thereof |
| 12/13/2007 | WO2007142323A1 Novel indazole derivative having spiro ring structure in side chain |
| 12/13/2007 | WO2007142308A1 Nitrogen-containing heterocyclic compound and thrombopoietin receptor activator |
| 12/13/2007 | WO2007142304A1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME |
| 12/13/2007 | WO2007142303A1 Method for controlling the amount of gene product, and agent for controlling the amount of gene product |
| 12/13/2007 | WO2007142288A1 Treatment of ischemic disease using erythropoietin |
| 12/13/2007 | WO2007142253A1 2-cyanopyrrolidine derivative |
| 12/13/2007 | WO2007142217A1 1-phenylpyridone derivative |
| 12/13/2007 | WO2007142139A1 Method of identifying candidate for remedy of acute myeloid leukemia |
| 12/13/2007 | WO2007142130A1 Maitake mushroom extract and composition for enhancing the production of sebum comprising the extract |
| 12/13/2007 | WO2007142118A1 Composition for preventing the occurrence of cardiovascular event in multiple risk patient |
| 12/13/2007 | WO2007142096A1 Inhibitor of inducible nitric oxide synthase, beverage/food, and neutraceutical food |
| 12/13/2007 | WO2007141974A1 Nonhuman model animal of hypertension |
| 12/13/2007 | WO2007141926A1 Extended amyloid beta production inhibitor |
| 12/13/2007 | WO2007108559A8 Agonistic antibody directed against human thrombopoietin receptor |
| 12/13/2007 | WO2007105171A3 Killing of selected cells |
| 12/13/2007 | WO2003037306A3 Inhalation of vapour of therapeutical substances, like e.g. cannabis extract |
| 12/13/2007 | US20070287826 Production of high molecular mass lectins |
| 12/13/2007 | US20070287743 Adamantyl Pyrrolidin-2-One Derivatives as 11-Beta Hydroxtsteroid Dehydrogenase Inhibitors |
| 12/13/2007 | US20070287740 Compositions and methods of treating middle-of-the night insomnia |
| 12/13/2007 | US20070287731 1-Benzyl-3-[3-(3,5-dimethyl-phenyl)-5,5-dimethyl-[1,2,4]oxadiazol-4-yl]-urea; nuclear receptor-based inducible gene expression system |
| 12/13/2007 | US20070287714 Warming and Nonirritating Lubricant Compositions and Method of Comparing Irritation |
| 12/13/2007 | US20070287713 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 12/13/2007 | US20070287710 Piperidinediyl-containing sulfonamide; NPY Y5 receptor antagonist activity; antiobesity agent or anorectic agent |
| 12/13/2007 | US20070287709 Novel arylamino N-heteraryls as MEK inhibitors |
| 12/13/2007 | US20070287697 Cgrp Receptor Antagonists |
| 12/13/2007 | US20070287677 Rad51 Expression Inhibitors, Pharmaceutical Agents Containing The Inhibitors As Active Ingredients, And Uses Thereof |
| 12/13/2007 | US20070287670 Human glucagon-like peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 12/13/2007 | US20070287668 Methods, kits, and antibodies for detecting parathyroid hormone |
| 12/13/2007 | US20070287665 Urotensin-II agonists and antagonists |
| 12/13/2007 | US20070287662 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 12/13/2007 | US20070287173 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 12/13/2007 | US20070286910 Method and Composition for Administering Bioactive Compounds Derived from Morinda Citrifolia |
| 12/13/2007 | US20070286905 Method for the Preparation of Trans-or Cis-Diammoniumdichlorodihydroxoplatinum(IV) and the Use Thereof in the Production of Pharmaceutical Active Substances |
| 12/13/2007 | US20070286904 Structured materials |
| 12/13/2007 | US20070286877 Multi-functional protective textiles and methods for decontamination |
| 12/13/2007 | US20070286873 Recombinant Influenza H5 Hemagluttinin Protein And Nucleic Acid Coding Therefor |
| 12/13/2007 | US20070286870 Modified Vp1-Capsid Protein Of Parvovirus B19 |
| 12/13/2007 | US20070286865 Use of HE4 and other biochemical markers for assessment of ovarian cancers |
| 12/13/2007 | US20070286862 Cancer Associated Antigens |
| 12/13/2007 | US20070286856 Enzyme is a drug target; cancer, inflammatory diseases such as psoriasis |
| 12/13/2007 | US20070286852 Sppls as Modifiers of the P53 Pathway and Methods of Use |
| 12/13/2007 | US20070286823 Compositions having anti-dental caries function |
| 12/13/2007 | US20070286807 Method Of Inducing Or Modulating Immune Response |
| 12/13/2007 | US20070286806 Methods and Compositions for Modulating a Steroid Receptor |
| 12/13/2007 | CA2654978A1 Gene involved in immortalization of human cancer cell and use thereof |
| 12/13/2007 | CA2654154A1 Treatment of ischemic diseases using erythropoietin |
| 12/13/2007 | CA2653787A1 Composition for preventing the occurrence of cardiovascular event in multiple risk patient |
| 12/13/2007 | CA2653424A1 Novel indazole derivative having spiro ring structure in side chain |
| 12/12/2007 | EP1865319A1 Method of testing whether a tumor is susceptible to treatment with a ginkgo biloba extract or Ginkgolide B by testing whether the cancer is characterized by an over-expression of peripheral-type benzodiazepine receptor protein |
| 12/12/2007 | EP1865055A1 Component of bromelain |
| 12/12/2007 | EP1864994A1 Par-2 agonist |
| 12/12/2007 | EP1864981A1 Thrombopoietin mimetics |
| 12/12/2007 | EP1864975A2 Novel compounds |
| 12/12/2007 | EP1864967A1 Method for preparing O-desmethyl-venlafaxine |
| 12/12/2007 | EP1864681A1 Growth factor modified protein matrices for tissue engineering |
| 12/12/2007 | EP1864670A1 Sucrase activity inhibitor, glucoamylase activity inhibitor and food and feed containing the same |
| 12/12/2007 | EP1864664A1 Pharmaceutical preparation |
| 12/12/2007 | EP1864663A1 Preventive and/or therapeutic agent for rheumatoid arthritis |
| 12/12/2007 | EP1864661A1 Prophylactic/therapeutic agent for stress-induced bowel disease |
| 12/12/2007 | EP1864659A1 Lignane compound-containing oil-in-water emulsion and composition comprising the same |
| 12/12/2007 | EP1864658A1 Agent for alleviating vascular insufficiency |
| 12/12/2007 | EP1863573A1 Treatment of laminitis |
| 12/12/2007 | EP1863522A2 Compounds having activity in correcting mutant-cftr processing and uses thereof |